EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Clinical characteristics of ventricular arrhythmia in NIDDM: Evaluation of arrhythmia using Holter ECG monitoring



Clinical characteristics of ventricular arrhythmia in NIDDM: Evaluation of arrhythmia using Holter ECG monitoring



Journal of the Japan Diabetes Society 37(5): 349-355



We have reported that the prevalence of sudden death in diabetic subjects is higher than that in the general population, but the precise mechanism of sudden death in diabetics is still unclear. Malignant arrhythmia might be one of the possible causes of sudden death. Herein, we have investigated the frequency and clinical characteristics of ventricular premature contraction (VPC) using 24 hr-Holter ECG monitoring in 444 NIDM (group D), and in 80 age and sex matched non-diabetic controls (group C) without organic heart disease. 1) In group D, Multifocal VPC, ventricular tachycardia and/or R-on-T phenomenon were more frequently observed as compared with controls. 2) Malignant arrhythmia in group D was associated with aging, ischemic heart disease, nephropathy, and autonomic neuropathy. These results indicate that further cardiac examination using Holter ECG should be recommended for diabetics with cardiac complications nephropathy, and/or autonomic neuropathy in order to prevent sudden unexpected death.

(PDF emailed within 1 workday: $29.90)

Accession: 008324873

Download citation: RISBibTeXText



Related references

The role of Holter monitoring and electrophysiological studies in the evaluation of ventricular anti-arrhythmia agents. Archives des Maladies du Coeur et des Vaisseaux 84 Spec No 2: 21-25, 1991

Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone. American Journal of Cardiology 55(6): 709-712, 1985

Holter monitoring of ventricular arrhythmia during the 24 first hours of myocardial infarction treated with intravenous thrombolysis. Archives des Maladies du Coeur et des Vaisseaux 85(12): 1781-1788, 1992

Study on sudden death and ventricular tachy arrhythmia by holter monitoring in hypertrophic nonobstructive cardio myopathy. Japanese Circulation Journal 46(7): 743, 1982

Reproducibility of exercise-induced ventricular arrhythmia in patients undergoing evaluation for malignant ventricular arrhythmia. American Journal of Cardiology 63(11): 697-701, 1989

Response of ventricular extrasystolic arrhythmia to the action of verapamil. Evaluation by the Holter system. Arquivos Brasileiros de Cardiologia 31 Suppl 1: 79-82, 1978

Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia. Revista Portuguesa de Cardiologia 9(1): 33-39, 1990

Correlation of ventricular arrhythmia detected during holter monitoring treadmill testing and isometrics in convalescent myo cardial infarction patients. Chest 68(3): 409, 1975

Comparison of the efficacy of propafenone and hydroquinidine in stabilized extrasystolic ventricular arrhythmia by means of dynamic electrocardiographic Holter monitoring. Giornale Italiano di Cardiologia 14(5): 345-351, 1984

Clinical significance of holter monitoring and treadmill stress test for the detection of arrhythmia. Japanese Journal of Medicine 20(4): 286, 1981

Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia. Acta Cardiologica 34(1): 35-50, 1979

Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia. Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123, 1980

Clinical significance of second degree Wenckebach type sinoatrial block identified during Holter monitoring in patients with symptoms suggestive of arrhythmia. Europace 17(1): 123-130, 2015

Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study. Zeitschrift für Kardiologie 81 Suppl 4: 145-149, 1992

Arrhythmia surveillance by transtelephonic monitoring: comparison with Holter monitoring in symptomatic ambulatory patients. American Heart Journal 98(4): 459-464, 1979